MolecuLight

MolecuLight is a Canadian medical imaging company founded in 2012, based in Toronto, with a presence in the US.

The company specializes in developing and commercializing proprietary fluorescent imaging technology for real-time wound care assessment. It offers the only FDA Class II-cleared diagnostic device for detecting bacterial burden in wounds, enhancing treatment decisions for healthcare professionals. MolecuLight's primary products include the MolecuLight i:X®, a handheld device that visualizes bacteria in chronic wounds, and the MolecuLight DXTM, which provides enhanced imaging capabilities. These devices support real-time bacterial detection, digital wound measurement, and procedural guidance, integrating seamlessly with electronic health records. The company targets the global wound care market, serving healthcare practitioners and facilities to improve healing rates and reduce costs. MolecuLight is committed to advancing health equity in wound care through its innovative imaging solutions.